Skip to main contentSkip to navigation
Peptide Atlas
Back to Case Studies
Protocol ExampleBPC-1578 weeksPositive Outcome

BPC-157 for Tendon Recovery: 8-Week Protocol

A detailed protocol example for using BPC-157 to support tendon recovery following a sports injury.

January 15, 2024Anonymized

Research Use Only

This case study is for educational and research purposes only. It should not be considered medical advice. Always consult with qualified healthcare providers before considering any peptide protocols. Individual results may vary.

This case study outlines a comprehensive 8-week protocol for using BPC-157 to support tendon recovery. The individual had experienced a partial tear in the Achilles tendon and was looking for research-based approaches to support healing. **Background:** The individual was a recreational athlete who sustained an injury during training. After initial medical evaluation, they were interested in exploring research peptides as part of their recovery protocol. **Protocol Overview:** The protocol was structured in phases, starting with a loading phase and transitioning to maintenance dosing. Careful attention was paid to injection site rotation and sterile technique. **Key Observations:** - Improved range of motion was noted by week 4 - Reduced discomfort during daily activities - Gradual return to light activity by week 6 - Full protocol completion at 8 weeks **Important Notes:** This is a research protocol example only. All protocols should be discussed with qualified healthcare providers. Individual results may vary, and this should not replace medical treatment.

Protocol

1Week 1

Dosage: 250 mcg

Frequency: Twice daily

Notes: Loading phase, subQ injection

2Week 2

Dosage: 250 mcg

Frequency: Twice daily

Notes: Continued loading phase

3Week 3

Dosage: 200 mcg

Frequency: Twice daily

Notes: Transition to maintenance

4Week 4

Dosage: 200 mcg

Frequency: Twice daily

Notes: Maintenance phase

5Week 5

Dosage: 200 mcg

Frequency: Twice daily

Notes: Maintenance phase

6Week 6

Dosage: 200 mcg

Frequency: Twice daily

Notes: Maintenance phase

7Week 7

Dosage: 200 mcg

Frequency: Twice daily

Notes: Maintenance phase

8Week 8

Dosage: 200 mcg

Frequency: Twice daily

Notes: Final week of protocol

Outcome

The individual reported improved mobility and reduced discomfort. Range of motion improved significantly, and they were able to gradually return to light activities. No adverse effects were reported during the protocol period.

Key Findings

  • Improved range of motion by week 4
  • Reduced discomfort during daily activities
  • Gradual return to activity by week 6
  • No reported adverse effects

Lessons Learned

  • Consistent dosing schedule is important
  • Injection site rotation helps prevent irritation
  • Patience is key - results may take several weeks
  • Medical supervision is essential
recoverytendoninjuryprotocol